Company / Shareholders' Equity
Biofrontera Inc. Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$4.4M
FY2025
5-year range
$4.4M / $23.9M
FY2021-FY2025
Trend
-7.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $24M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025 with a 3-year CAGR of -8.7%.
Declined from $24M to $4M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -8.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -8.7%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 7.5% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.4M | -7.5% |
| FY2024 | $4.8M | -79.9% |
| FY2023 | $23.9M | +309.7% |
| FY2022 | $5.8M | +0.0% |
| FY2021 | $5.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026